XML 22 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Operating Activities            
Net Income (Loss) $ 84,438 $ (30,402) $ 225,621 $ (115,996)    
Adjustments to reconcile net income (loss) to net cash provided by operating activities:            
Stock-based compensation 5,000 7,000 10,511 22,093    
Pension credit and contributions     (38,027) (11,024)    
Depreciation     27,056 27,498    
Amortization of contract intangible assets and liabilities     440 429    
Amortization of other intangible assets     83,368 83,323    
Income on equity investments, net (52,568) (40,761) (91,705) (77,798)    
Distributions from equity investments     158,926 149,650    
Non-cash loss on extinguishment and modification of debt     0 6,823    
Original issue discount payments     0 (6,873)    
Write-downs of investment 0 58,800 0 180,800    
Amortization of debt issuance costs and original issue discount     3,718 4,127    
Gain on sales of spectrum (Note 8) 0 0 (133,197) 0    
Gain on sale of business     0 (34,510)    
Gain on investment transactions     (3,888) (4,950)    
Gain on sale of real estate, net     0 (300)    
Other non-operating gain, net     (91) (45)    
Changes in working capital items:            
Accounts receivable, net     12,917 32,074    
Prepaid expenses and other current assets     (16,825) 14,659    
Accounts payable     (1,857) (8,896)    
Employee compensation and benefits, accrued expenses and other current liabilities     (13,993) (17,014)    
Deferred revenue     2,801 (2,726)    
Income taxes     7,271 24,756    
Change in broadcast rights, net of liabilities     (28,612) (11,893)    
Deferred income taxes     17,405 (141,944)    
Other, net     (898) 10,434    
Net cash provided by operating activities     220,941 122,697    
Investing Activities            
Capital expenditures (11,274) (13,465) (24,947) (28,099)    
Net proceeds from the sale of business     0 554,487    
Sale of partial interest in equity investment     833 0    
Proceeds from sales of real estate and other assets     58 59,751    
Proceeds from the sale of investments     3,057 4,950    
Other, net     3,255 805    
Net cash (used in) provided by investing activities     (17,744) 591,894    
Financing Activities            
Long-term borrowings     0 202,694    
Repayments of long-term debt     0 (589,661)    
Long-term debt issuance costs     0 (1,689)    
Payments of dividends     (43,847) (542,665)    
Tax withholdings related to net share settlements of share-based awards     (5,723) (7,351)    
Proceeds from stock option exercises     581 10,013    
(Distributions to)/contributions from noncontrolling interests     (2) 1,003    
Net cash used in financing activities     (48,991) (927,656)    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash     154,206 (213,065)    
Cash, cash equivalents and restricted cash, beginning of period (1)     691,251 611,198 [1] $ 611,198 [1]  
Cash, cash equivalents and restricted cash, end of period 845,457 398,133 845,457 398,133 691,251  
Cash, Cash Equivalents and Restricted Cash are Comprised of:            
Cash and cash equivalents 828,850 380,567 828,850 380,567 673,685  
Restricted cash 16,607 17,566 16,607 17,566 17,566 $ 17,566
Cash, cash equivalents and restricted cash, end of period $ 845,457 $ 398,133 845,457 398,133 $ 691,251  
Supplemental Schedule of Cash Flow Information            
Interest     79,027 76,264    
Income taxes, net     $ 64,294 $ 68,685    
[1] (1)Cash, cash equivalents and restricted cash at the beginning of the six months ended June 30, 2017 of $611 million are comprised of $595 million of cash, cash equivalents and restricted cash from continuing operations as reflected in the Company’s unaudited Condensed Consolidated Balance Sheets and $16 million of cash, cash equivalents and restricted cash reflected in current assets of discontinued operations.